Impression Healthcare's Dr Sud Agarwal on obstructive sleep apnoea and cannabinoids
“The cost of obstructive sleep apnoea to the Australian population is $21.2 billion per annum.”
Dr Sud Agarwal presented at Impression Healthcare’s (ASX: IHL) annual general meeting on Friday 4th October 2019.
For the full video visit:
Small Caps is Australia’s #1 site for market news & information on ASX listed small cap companies.